Research on Synthesizing N-Acetyl-Dl-Leucine for Pharmaceutical Products
Overview
Considering a rising incidence of vertigo disorders in our high school friends (15–40%), this research is aiming for vestibular disease treatment, acetyl-DL-leucin (ADLL, a world-wide therapy). Inspired by classical organic chemistry, ADLL was synthesized and co-crystalized in polyethylene glycol (PEG 6000) for pharmaceuticals. Acylation of L-leucine by acetic anhydride (Ac2O) was conducted, in which reaction conditions (molar ratio, volume, temperature, and scale-up factors) were investigated; data was analyzed using an artificial neural network (ANN). The racemization process was carried out by treating acetyl-L-leucine with Ac2O in presence of NaOH, a unique way for racemize amino acids. Finally, modern techniques (dropping pills and fluid-bed) were employed to co-crystallize ADLL with PEG-6000, resulting a novel drug delivery system for patients. The synthesis process provided ADLL successfully. ANN showed that the Ac2O: L-leucine ratio had a substantial impact on the yield of final product (%); the scaling-up factor, the second-effective factor, could overwhelm issues of volume, temperatures, and purifying conditions. The obtained product was not-only complied with pharmaceutical standards but also equivalent to commercials (assay, polymorphisms, and stability). Finally, the micron-sized ADLL-PEG powder was expected to improve patient compliance when compared to conventional tablets in terms of dose form size, shape, and dissolution profile. Overall, we proposed a batch-technology-based for ADLL synthesis (even at 1 kg scale) that is simple and feasible for implementation worldwide. Finally, this project contributes to the understanding about acylation, racemization, and co-crystallization, aiming for potential pharmaceutical applications.
Competition history
- ISEF 2024
Resources
Related projects
ISEF · 2014
Development of a Therapeutic Drug for Alzheimer’s Disease: A Chemical Approach to Cease Amyloidosis
ISEF · 2025
N-3-Hydroxyphenyl Alkanamide for Epileptic Seizure Management
ISEF · 2018
Synthesis and Separation of Chiral Compounds in the Preparation of a PET Radiotracer Targeting Synaptic Vesicle Glycoprotein 2A
JSHS · 2025
Combating Alzheimer’s Disease: Design and Synthesis of a Novel Drug Molecule for Targeted Metal Chelation Therapy
CSEF · 2007
Synthesis of a Diketopiperazine: The Key Structure of the Norgeamide
ISEF · 2021
Investigation on Amino Acid DL-Phenylalanine’s Ability as a Cognitive Stimulant in V. costata
ISEF · 2019
A Novel Approach to the Synthesis of 3,5-disubstituted delta-2-isoxazoline as a Precursor to Various Diabetic Medications
CSEF · 2015
The Effect of Various Human Body Conditions on the Racemization of Doxylamine Succinate
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: Regeneron International Science and Engineering Fair